TheClubDeal is a Brussels-based VC-PE fund manager
The fund invests in scale-ups and SMEs located in Belgium and northern France
Investing in growth sectors
TheClubDeal Fund II invests in advanced stage Biotech & Medtech with preferred focus on gene therapy, liver disease and NASH related diseases treatments, synthetic biology, and parapharmacy. It targets companies that both drive medical innovation across the value chain and enable that innovation to improve the life of patients with unmet medical needs.
Smart Living is a trend that involves improved standards in several aspects of day-to-day life, ranging from mixed-use real estate, hospitality, workplaces and the way people are transported and fed whilst striving for wellness, efficiency, economy and reduction of the carbon footprint.
The Technology sector embodies companies involved in the research, development and/or distribution of technologically based goods and services which do contribute on the local value creation. While focus is on IT driven technologies, industrial innovative technologies (food, chemistry,…) will not be excluded.
In the News
TheClubDeal Lance Son Nouveau Fonds d’Ancrage À 50 Millions | L'Echo
Allier recherche de rendement, création d’emplois et aide à l’ancrage des entreprises en Belgique: c’est le pari que veut relever TheClubDeal, version 2021.
Best Private Equity Funds 2021 | Highly Recommended by Leaders League
TheClubDeal is proud to be part of the best private equity funds out of the acclaimed 2021 Leaders League's ranking.
Univercells is a medical engineering company having developed technologies aiming at reducing the cost of vaccines and biologics by significant factors
YUST has created a fast-growing and innovative smart living concept with strong operational results for the first residence in Antwerp
The company brings unique solutions, in Belgium and other countries, to private and public institutions, to help the management be even more efficient with the support of data-driven decisions. The new capital will be used, among others, to finalise its transition towards a subscription model and bring the solution to even more companies.
BCI Pharma is a company existing for 5 years in Montpellier, France. It has been relocated partly to Liège following a 3MM capital increase led by TheClubDeal